CASP2 and neoplasm: One commonly observed feature of caspase-2-deficient tumours and MEFs is enhanced aneuploidy,4, 11, 12, 14, 15, 17 likely because of reduced or inefficient apoptotic removal of aberrant cells in the absence of caspase-2.